End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.45 SEK | +13.16% | +13.16% | +29.00% |
05-02 | ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024 | CI |
02-22 | ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
Sales 2022 | 0.31 3.38 24.94 | Sales 2023 | 0.14 1.51 11.11 | Capitalization | 83.71M 905M 6.67B |
---|---|---|---|---|---|
Net income 2022 | -7M -75.7M -558M | Net income 2023 | -6M -64.88M -478M | EV / Sales 2022 | 239,089,567 x |
Net cash position 2022 | 7.37M 79.67M 587M | Net cash position 2023 | 6.49M 70.21M 517M | EV / Sales 2023 | 553,698,961 x |
P/E ratio 2022 |
-11.3
x | P/E ratio 2023 |
-12.2
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
1 day | +13.16% | ||
1 week | +13.16% | ||
Current month | +13.16% | ||
1 month | +21.70% | ||
3 months | +29.00% | ||
6 months | +33.82% | ||
Current year | +29.00% |
Managers | Title | Age | Since |
---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 31/12/17 |
Markus Fritzsche
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karina Kilinski
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 31/12/17 |
Founder | 44 | 31/12/17 | |
Karina Kilinski
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 7.65 | +18.60% | 31,510 |
02/05/24 | 6.45 | +13.16% | 42,540 |
30/04/24 | 5.7 | 0.00% | 17 |
29/04/24 | 5.7 | 0.00% | 1,345 |
26/04/24 | 5.7 | 0.00% | 367 |
End-of-day quote NORDIC GROWTH MARKET, May 01, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+29.00% | 9M | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- ODI Stock